Latest News

Endologix announces 36-month results of DETOUR2 study

Endologix has announced the final 36-month results from the DETOUR2 study—a prospective, single-arm, international, multicentre clinical evaluation of the novel Detour system for fully...

From the Editor

Who harmed who?

In his address at the 2024 Vascular Annual Meeting (VAM), Society for Vascular Surgery Immediate Past President Joseph Mills, MD, eloquently stated—and please excuse...

The CLTI conundrum: My spirited journey through the CLTI saga

Welcome to the CLTI Chronicles, a saga of mystery, medi­cine and misadventures in limb salvage unfolding weekly in my office, where the drama of...

SVS news

Education and representation at core of inclusivity efforts for DEI committee

The SVS Diversity, Equity and Inclusion (DEI) Committee continues to make strides in advancing inclusivity within the organization, with several projects underway to address...

ABS seeks vascular surgeon nominations for council position

The American Board of Surgery (ABS) is accepting nominations for vascular surgeons to serve on its council for a six-year term, beginning on...

Commentary

Hospitals represent one of the largest industries in the U.S., with revenues greater than $1.4 trillion. The American Hospital Association reports that there are 5,200 nonfederal, short-term general, and other special hospitals in the country, of which 3,000 are...

VAM news

Vascular surgeon-scientists may submit their research for presentation at the 2025 Vascular Annual Meeting (VAM) in June starting from Nov. 6 through Wednesday, Jan. 8, 2025.  VAM research—both clinical and translational—is considered for presentation in several different forums that appeal...

Most read

From the editor

Commentary